Evidence map›Paper›PMID 19279209›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection.

Jerry R Aldridge, Carson E Moseley, David A Boltz, Nicholas J Negovetich, Cory Reynolds, John Franks, Scott A Brown, Peter C Doherty, Robert G Webster, Paul G Thomas

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 257 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
257citing papers in PubMed, 1 pooled it
28.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

257 citing papers in PubMed, 1 synthesis or guideline pooled it, 420 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Viruses · 2026
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. ZBP1-driven cell death in severe influenza.Trends in microbiology · 2025
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

197 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Jerry R AldridgeDivision of Virology, Department of Infectious Diseases, and Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Carson E Moseley
David A Boltz
Nicholas J Negovetich
Cory Reynolds
John Franks
Scott A Brown
Peter C Doherty
Robert G Webster
Paul G Thomas
St. Jude Children's Research Hospital · US

Funding

PROFESSIONAL ONCOLOGY EDUCATION PROGRAMR25CA023944 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI SUZANNE A. GRONEMEYER · 1986 to 2026
$8.3M
Protective Cell-Mediated Immunity Against Lethal H5N1 Influenza A VirusesR01AI070251 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI DOHERTY, PETER C · 2006 to 2010
$2.0M
Role of dendritic cells in lethal H5N1 influenza infectionF32AI078667 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI ALDRIDGE, JERRY R · 2009 to 2010
$106k
NCI NIH HHS R25 CA023944NIAID NIH HHS F32 AI078667NIAID NIH HHS HHSN266200700005CNIAID NIH HHS R01 AI070251
6 · The paper itself

Abstract

Respiratory infection with highly pathogenic influenza A viruses is characterized by the exuberant production of cytokines and chemokines and the enhanced recruitment of innate inflammatory cells. Here, we show that challenging mice with virulent influenza A viruses, including currently circulating H5N1 strains, causes the increased selective accumulation of a particular dendritic cell subset, the tipDCs, in the pneumonic airways. These tipDCs are required for the further proliferation of influenza-specific CD8(+) T cells in the infected lung, because blocking their recruitment in CCR2(-/-) mice decreases the numbers of CD8(+) effectors and ultimately compromises virus clearance. However, diminution rather than total elimination of tipDC trafficking by treatment with the peroxisome proliferator-activated receptor-gamma agonist pioglitazone moderates the potentially lethal consequences of excessive tipDC recruitment without abrogating CD8(+) T cell expansion or compromising virus control. Targeting the tipDCs in this way thus offers possibilities for therapeutic intervention in the face of a catastrophic pandemic.

Indexed as

AnimalsCD8-Positive T-LymphocytesCell MovementCell ProliferationDendritic CellsInfluenza A virusInfluenza A Virus, H5N1 SubtypeLung DiseasesMiceMice, KnockoutNitric Oxide Synthase Type IIOrthomyxoviridae InfectionsReceptors, CCR2Tumor Necrosis Factor-alphaCcr2 protein, mouseNitric Oxide Synthase Type IIReceptors, CCR2Tumor Necrosis Factor-alpha

Identifiers

PMID19279209
PMCPMC2664048
OpenAlexW1977142289

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.